SVQ Sinovac Biotech Ltd.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of Sinovac Biotech Ltd. to Sinovac (Cayman) Limited and Sinovac Amalgamation Sub Limited for $7.00 Per Share is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--

The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Sinovac Biotech Ltd. (NASDAQ:SVA) stock prior to June 26, 2017.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Sinovac to Sinovac (Cayman) Limited and Sinovac Amalgamation Sub Limited for US$7.00 per share. As of June 23, 2017, the buyers own approximately 29.5% of the issued and outstanding shares of Sinovac. To learn more about the action and your rights, go to:

http://www.zlkdocs.com/SVA-Info-Request-Form-ma-5898

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Eduard Korsinsky, Esq.

30 Broad Street - 24th Floor

New York, NY 10004

Tel: (212) 363-7500

Toll Free: (877) 363-5972

Fax: (212) 363-7171

www.zlk.com

EN
26/06/2017

Underlying

SVQSinovac Biotech Ltd.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Sinovac Biotech Ltd.

 PRESS RELEASE
Free
SVQ Sinovac Biotech...

September 1st Deadline Alert: The Law Offices of Howard G. Smith Remin...

BENSALEM, Pa.--(BUSINESS WIRE)-- Law Offices of Howard G. Smith reminds investors of the September 1, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA) securities between April 30, 2013 to May 16, 2017, inclusive (the “Class Period”). Sinovac investors have until September 1, 2017 to file a lead plaintiff motion. Investors suffering losses on their Sinovac investments are encouraged to conta...

August 30, 2017 1 EN
 PRESS RELEASE
Free
SVQ Sinovac Biotech...

The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf...

NEW YORK--(BUSINESS WIRE)-- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Sinovac Biotech Ltd. (NASDAQ:SVA) who purchased shares between April 30, 2013 and May 16, 2017. The action, which was filed in District of New Jersey, alleges that the Company violated federal securities laws. In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (1) Defendant Weidong Yin,...

July 21, 2017 1 EN
 PRESS RELEASE
Free
SVQ Sinovac Biotech...

The Klein Law Firm Announces a Class Action Filed on Behalf of Sinovac...

NEW YORK--(BUSINESS WIRE)-- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Sinovac Biotech Ltd. (NASDAQ: SVA) who purchased shares between April 30, 2013 and May 16, 2017. The action, which was filed in District of New Jersey, alleges that the Company violated federal securities laws. In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (1) Defendant Weid...

July 20, 2017 1 EN
 PRESS RELEASE
Free
SVQ Sinovac Biotech...

SVA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors ...

NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in District of New Jersey on behalf of investors who purchased Sinovac Biotech Ltd. ("Sinovac Biotech Ltd.") (NASDAQ:SVA) securities between April 30, 2013 and May 16, 2017. Click here to learn about the case: http://www.wongesq.com/pslra-sb/sinovac-biotech-ltd?wire=2. There is no cost or obligation to you. According to the complaint, throughout the Class Period, the Company issued materially fal...

July 19, 2017 1 EN
 PRESS RELEASE
Free
SVQ Sinovac Biotech...

SVA SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Invest...

NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in District of New Jersey on behalf of investors who purchased Sinovac Biotech Ltd. ("Sinovac Biotech Ltd.") (NASDAQ:SVA) securities between April 30, 2013 and May 16, 2017. Click here to learn about the case: http://www.wongesq.com/pslra-sb/sinovac-biotech-ltd?wire=2. There is no cost or obligation to you. According to the complaint, throughout the Class Period, the Company issued materially fal...

July 18, 2017 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch